Abruptio Placentae clinical trials
The registry lists 23 studies for Abruptio Placentae across more than 10 countries. 4 are recruiting or about to start. 6 of them are mainly about Abruptio Placentae (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-28.
Get an email when these change. Save the Abruptio Placentae studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of Jena (1) · Assistance Publique - Hôpitaux de Paris (1) · Hawler Medical University (1) · Centre Hospitalier Intercommunal Creteil (1) · Puerta de Hierro University Hospital (1) · Tel-Aviv Sourasky Medical Center (1) · HOSPITAL GINECO OBSTETRICO ISIDRO AYORA (1) · Soroka University Medical Center (1)
What is being tested here
Drugs under test in Abruptio Placentae studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Aspirin | 1 | 2 | 2 |
| Magnesium Sulfate | 0 | 1 | 2 |
| Enoxaparin | 0 | 1 | 2 |
| Tranexamic Acid | 0 | 0 | 1 |
| Enoxaparin sodium | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Oct 2027PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) · Copenhagen University Hospital, Hvidovre
Who these studies take
Of the 3 Abruptio Placentae studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 3 (100%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 3 (100%) | 0 (0%) |
| 30 | 3 (100%) | 0 (0%) |
| 40 | 3 (100%) | 0 (0%) |
| 50 | 3 (100%) | 0 (0%) |
| 65 | 3 (100%) | 0 (0%) |
| 75 | 3 (100%) | 0 (0%) |
| 85 | 3 (100%) | 0 (0%) |
Across all 23 studies, recruiting or not: 43% stop at 75 or younger and 43% at 65; 17% take children; 96% are for women only and 0% for men only; 35% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 23 of 23. search them.
- Enhancing Prediction of Adverse Pregnancy Outcomes in Africa Through Partnerships and InnovationRecruitingNCT078448761 country
- Chronic Hypertension and Acetyl Salicylic Acid in PregnancyRecruitingNCT04356326Phase 31 country
- PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)RecruitingNCT072634901 country
- Effect of Placenta Delivery Method on Pain, Bleeding and ComfortNot yet recruitingNCT06413186Not applicable1 country
- Tranexamic Acid as an Intervention in Abruptio PlacentaCompletedNCT05840471Not applicable1 country
- The Relationship Between Isolated Head Trauma During Pregnancy and Preterm BirthCompletedNCT066855491 country
- Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in NewbornsCompletedNCT066533741 country
- Plasma Concentration of Biological Markers in Placental AbruptionTerminatedNCT037821681 country
- BH4 Blood Levels Variations in Pre Eclamptic WomenCompletedNCT058473611 country
- Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.CompletedNCT034553871 country
- Spanish Registry of Pregnant Women With COVID-19Status unknownNCT045589961 country
- Study on Retroplacental Hematomas in FinistèreCompletedNCT041686061 country
- Normotensive and Hypertensive Placental AbruptionsCompletedNCT04449601
- Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)CompletedNCT00014989Phase 31 country
- The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio PlacentaTerminatedNCT012793691 country
- Magnesium Sulfate vs Placebo for Placental AbruptionCompletedNCT00186069Not applicable1 country
- Progesterone for First Trimester Vaginal BleedingWithdrawnNCT01501890Not applicable1 country
- Proof of Concept Study of a Sucker Hemostatic Intra Uterine in Postpartum Hemorrhage After Abruptio Placenta AssistedTerminatedNCT01589744Not applicable1 country
- Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy OutcomeCompletedNCT01068795Not applicable1 country
- Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe PreeclampsiaCompletedNCT00986765Phase 31 country
- Low Dose Aspirin for the Prevention of PreeclampsiaStatus unknownNCT01890005Phase 31 country
- Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk PregnanciesCompletedNCT01355822Phase 1/21 country
- Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma ActivityStatus unknownNCT005731181 country